Atovaquone

CAS No. 95233-18-4

Atovaquone ( BW 566C; BW 556C-80 )

Catalog No. M16808 CAS No. 95233-18-4

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 In Stock
25MG 73 In Stock
50MG 132 In Stock
100MG 196 In Stock
200MG 291 In Stock
500MG 489 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Atovaquone
  • Note
    Research use only, not for human use.
  • Brief Description
    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
  • Description
    Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
  • Synonyms
    BW 566C; BW 556C-80
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    DHODH; Cytochrome b
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    95233-18-4
  • Formula Weight
    366.84
  • Molecular Formula
    C22H19ClO3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 5 mg/mL (13.62 mM)
  • SMILES
    O=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O
  • Chemical Name
    trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.
molnova catalog
related products
  • 6PGD-IN-S3

    6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).

  • Octanoic acid

    CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.

  • hDHODH-IN-5

    hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase.